ISS/SIC
Journal (WJS)
Congress
Create Account
Login
International Society of Surgery (ISS)
Société Internationale de Chirurgie (SIC)
Integrated Societies: IATSIC | IASMEN | BSI | ISDS
STARR PLUS LASER-ASSISTED HEMORRHOIDOPEXY VERSUS. STAR ALONE FOR ODS PATIENTS WITH PROLAPSED HEMORRHOIDS
waheebradman@yahoo.com
 
Back
Slot ID
Abstract Title
STARR PLUS LASER-ASSISTED HEMORRHOIDOPEXY VERSUS. STAR ALONE FOR ODS PATIENTS WITH PROLAPSED HEMORRHOIDS
Author Details
No. of Authors
1
Including the presenting author
Author 1
Waheeb Al-Kubati waheebradman@yahoo.com 21 September University Surgery Sana'a Yemen *
Author 2
Author 3
Author 4
Author 5
Author 6
Author 7
Author 8
Author 9
Author 10
Author 11
Author 12
Presenting Author Name
Waheeb Al-Kubati
Presenting Author Email
waheebradman@yahoo.com
Presenting Author Country
Yemen
Abstract
Abstract type
Oral only
Introduction *
Obstructed defecation syndrome (ODS), often linked to rectal intussusception and advanced hemorrhoids, poses significant therapeutic challenges. While stapled transanal rectal resection (STARR) is widely used, recurrence and complications persist. This study compares STARR combined with laser-assisted 4th-degree hemorrhoidopexy versus STARR alone in ODS patients with prolapsed hemorrhoids. It evaluates efficacy, safety, and inflammatory outcomes of combined STARR-laser therapy versus STARR alone, focusing on symptom relief, recurrence, complications, and patient satisfaction.
Material & Method *
In this prospective study (December 2019–January 2022), 200 patients with ODS and Grade III-IV hemorrhoids (Goligher’s classification) were randomized into Group A (STARR + laser hemorrhoidopexy, n=100) and Group B (STARR alone, n=100). Both groups underwent STARR using a CPH34HV stapler. Exclusion criteria included prior anorectal surgery, malignancies, or severe comorbidities. Follow-up spanned 12 months.
Results *
Group A demonstrated superior outcomes: higher success rate (96% vs. 80%, p<0.05), lower recurrence (3% vs. 20%, p<0.05), and fewer complications (5% vs. 30%, p<0.05), including reduced bleeding (1% vs. 11%) and fecal urgency (4% vs. 9%). Group B had higher reoperation rates (11% vs. 1%, p<0.05) and skin tag recurrence (30% vs. 2%). Pain scores and return-to-work timelines were comparable. Inflammatory markers (CRP, WBC) were significantly lower in Group A (p<0.05). Patient satisfaction (PGI-I) favored Group A (95% “very satisfied” vs. 70%, p<0.05).
Conclusion *
STARR with laser-assisted hemorrhoidopexy significantly improves outcomes in ODS and prolapsed hemorrhoids, offering reduced recurrence, complications, inflammation, and higher patient satisfaction compared to STARR alone. Integration of laser techniques may optimize management of complex hemorrhoidal disease, though long-term studies are warranted.
File Upload #1
https://storage.unitedwebnetwork.com/files/1258/10774149e78170d0cb2f1bea6dd9147a.jpeg
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
File Upload #2
https://storage.unitedwebnetwork.com/files/1258/582f46fc2a28e2f2a154f8602fd7d13b.jpeg
Only accept images in .jpg or .png format. The image size must not exceed 1 MB.
Category
Select Main Category
1 General Topics organized by ISS/SIC
Select Sub Category
1.09 Surgery in Low resource Countries
Submission Status
Withdrawn
Word counter
250
Abstract Prizes
Eligible for the BSI Free Paper Prize
No
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript conforming to the format of orignial articles in the World Journal of Surgery WJS by 30 November 2025
Eligible for the Grassi Prize
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
Eligible for the Kitajima Prize
No
- Author must be age 40 or younger
- One of the authors must be a member of ISDS
- Presenting author must register to the congress by 30 November 2025
- Author must submit a full-length manuscript to the World Journal of Surgery WJS by 30 November 2025
Vimeo Link